![]() |
|
|
Vol. 292, Issue 3, 846-852, March 2000
Istituto di Medicina Interna e Geriatria, Università
Cattolica del Sacro Cuore (G.M., A.V.G.); Istituto di
Analisi dei Sistemi ed Informatica del CNR (A.B., A.G.); and
Dipartimento di Informatica e Sistemistica, Università di Roma
"La Sapienza" (S.S.), Rome, Italy
The disposition of dodecanedioic acid (C12) was investigated in six
overnight-fasting healthy male volunteers, who received a 165-min i.v.
infusion of 42.45 mmol of C12 added to 150 µCi of
[1-12-14C]C12. Blood samples were collected up to 360 min after the start of infusion, and concentration of serum labeled C12
was determined. Expired radioactivity (µCi/min) was measured up to
600 min and at 24 h. The 24-h C12 urinary excretion was around 5%
of the administered amount. The percentage of C12 oxidized was
81.7 ± 9.5% (mean ± S.D.) of administered amount as
estimated from the area under the curve of measured
14CO2 expiration rate. C12 kinetics was
described by assuming a single compartment. A saturable rate of C12
tissue uptake (model A) and a linear rate of tissue uptake (model B)
were considered. The kinetics of CO2 produced by C12
oxidation was described by a fast pathway acting in parallel to a slow
pathway modeled by first order kinetics. Parameters of model B were
estimated for each subject, whereas model A was identified by fitting
the pooled data of all subjects. On the basis of estimates obtained
from model B, an average calorie delivery of 500 kcal/day was predicted in the plateau phase for the infusion rate of our experiments. When
estimated from model A, the maximal rate of tissue uptake was 0.38 ± 0.08 mmol/min, with a maximal calorie delivery of 750 kcal/day.
These results appear promising for C12 utilization in parenteral
nutrition, because C12 elimination with urine is low, whereas tissue
uptake and oxidation are rather efficient.
This article has been cited by other articles:
![]() |
S. Salinari, A. Bertuzzi, A. Gandolfi, A. V. Greco, A. Scarfone, M. Manco, and G. Mingrone Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1051 - E1058. [Abstract] [Full Text] [PDF] |
||||